The global Enoxaparin API market was valued at US$ 670 million in 2023 and is anticipated to reach US$ 1001.5 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.

Enoxaparin API Market

Enoxaparin is made from heparin and is one type of the low molecular weight heparin (LMWH). It is used as an anticoagulant that prevents the formation of blood clots also known as ‘blood thinner’. It is used to treat various conditions including deep vein thrombosis (DVT), pulmonary embolism in the lungs, acute coronary syndrome and heart attack.

North American market for Enoxaparin API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Enoxaparin API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Enoxaparin API include Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG and ChemWerth, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Enoxaparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin API.

Report Scope

The Enoxaparin API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enoxaparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enoxaparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Enoxaparin API Market Report

Report Metric	Details
Report Name	Enoxaparin API Market
Accounted market size in 2023	US$ 670 million
Forecasted market size in 2030	US$ 1001.5 million
CAGR	5.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Multi Vials Pre-Filled Syringes Others
Segment by Application	COVID-19 Pulmonary Embolism Atrial Fibrillation Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG, ChemWerth, Laboratorios Farmaceuticos ROVI SA, Gland Pharma Limited, Hanways Chempharma Co. Ltd, Changzhou Qianhong Biopharma, Shenzhen Hepalink Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enoxaparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enoxaparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Enoxaparin API Market growing?

Ans: The Enoxaparin API Market witnessing a CAGR of 5.9% during the forecast period 2024-2030.

What is the Enoxaparin API Market size in 2030?

Ans: The Enoxaparin API Market size in 2030 will be US$ 1001.5 million.

Who are the main players in the Enoxaparin API Market report?

Ans: The main players in the Enoxaparin API Market are Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG, ChemWerth, Laboratorios Farmaceuticos ROVI SA, Gland Pharma Limited, Hanways Chempharma Co. Ltd, Changzhou Qianhong Biopharma, Shenzhen Hepalink Pharmaceutical Group

What are the Application segmentation covered in the Enoxaparin API Market report?

Ans: The Applications covered in the Enoxaparin API Market report are COVID-19, Pulmonary Embolism, Atrial Fibrillation, Others

What are the Type segmentation covered in the Enoxaparin API Market report?

Ans: The Types covered in the Enoxaparin API Market report are Multi Vials, Pre-Filled Syringes, Others

1 Enoxaparin API Market Overview

1.1 Product Overview and Scope of Enoxaparin API

1.2 Enoxaparin API Segment by Type

1.2.1 Global Enoxaparin API Market Value Comparison by Type (2024-2030)

1.2.2 Multi Vials

1.2.3 Pre-Filled Syringes

1.2.4 Others

1.3 Enoxaparin API Segment by Application

1.3.1 Global Enoxaparin API Market Value by Application: (2024-2030)

1.3.2 COVID-19

1.3.3 Pulmonary Embolism

1.3.4 Atrial Fibrillation

1.3.5 Others

1.4 Global Enoxaparin API Market Size Estimates and Forecasts

1.4.1 Global Enoxaparin API Revenue 2019-2030

1.4.2 Global Enoxaparin API Sales 2019-2030

1.4.3 Global Enoxaparin API Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Enoxaparin API Market Competition by Manufacturers

2.1 Global Enoxaparin API Sales Market Share by Manufacturers (2019-2024)

2.2 Global Enoxaparin API Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Enoxaparin API Average Price by Manufacturers (2019-2024)

2.4 Global Enoxaparin API Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Enoxaparin API, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Enoxaparin API, Product Type & Application

2.7 Enoxaparin API Market Competitive Situation and Trends

2.7.1 Enoxaparin API Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Enoxaparin API Players Market Share by Revenue

2.7.3 Global Enoxaparin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Enoxaparin API Retrospective Market Scenario by Region

3.1 Global Enoxaparin API Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Enoxaparin API Global Enoxaparin API Sales by Region: 2019-2030

3.2.1 Global Enoxaparin API Sales by Region: 2019-2024

3.2.2 Global Enoxaparin API Sales by Region: 2025-2030

3.3 Global Enoxaparin API Global Enoxaparin API Revenue by Region: 2019-2030

3.3.1 Global Enoxaparin API Revenue by Region: 2019-2024

3.3.2 Global Enoxaparin API Revenue by Region: 2025-2030

3.4 North America Enoxaparin API Market Facts & Figures by Country

3.4.1 North America Enoxaparin API Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Enoxaparin API Sales by Country (2019-2030)

3.4.3 North America Enoxaparin API Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Enoxaparin API Market Facts & Figures by Country

3.5.1 Europe Enoxaparin API Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Enoxaparin API Sales by Country (2019-2030)

3.5.3 Europe Enoxaparin API Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Enoxaparin API Market Facts & Figures by Country

3.6.1 Asia Pacific Enoxaparin API Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Enoxaparin API Sales by Country (2019-2030)

3.6.3 Asia Pacific Enoxaparin API Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Enoxaparin API Market Facts & Figures by Country

3.7.1 Latin America Enoxaparin API Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Enoxaparin API Sales by Country (2019-2030)

3.7.3 Latin America Enoxaparin API Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Enoxaparin API Market Facts & Figures by Country

3.8.1 Middle East and Africa Enoxaparin API Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Enoxaparin API Sales by Country (2019-2030)

3.8.3 Middle East and Africa Enoxaparin API Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Enoxaparin API Sales by Type (2019-2030)

4.1.1 Global Enoxaparin API Sales by Type (2019-2024)

4.1.2 Global Enoxaparin API Sales by Type (2025-2030)

4.1.3 Global Enoxaparin API Sales Market Share by Type (2019-2030)

4.2 Global Enoxaparin API Revenue by Type (2019-2030)

4.2.1 Global Enoxaparin API Revenue by Type (2019-2024)

4.2.2 Global Enoxaparin API Revenue by Type (2025-2030)

4.2.3 Global Enoxaparin API Revenue Market Share by Type (2019-2030)

4.3 Global Enoxaparin API Price by Type (2019-2030)

5 Segment by Application

5.1 Global Enoxaparin API Sales by Application (2019-2030)

5.1.1 Global Enoxaparin API Sales by Application (2019-2024)

5.1.2 Global Enoxaparin API Sales by Application (2025-2030)

5.1.3 Global Enoxaparin API Sales Market Share by Application (2019-2030)

5.2 Global Enoxaparin API Revenue by Application (2019-2030)

5.2.1 Global Enoxaparin API Revenue by Application (2019-2024)

5.2.2 Global Enoxaparin API Revenue by Application (2025-2030)

5.2.3 Global Enoxaparin API Revenue Market Share by Application (2019-2030)

5.3 Global Enoxaparin API Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer Inc.

6.1.1 Pfizer Inc. Corporation Information

6.1.2 Pfizer Inc. Description and Business Overview

6.1.3 Pfizer Inc. Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Inc. Enoxaparin API Product Portfolio

6.1.5 Pfizer Inc. Recent Developments/Updates

6.2 Sanofi S.A.

6.2.1 Sanofi S.A. Corporation Information

6.2.2 Sanofi S.A. Description and Business Overview

6.2.3 Sanofi S.A. Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sanofi S.A. Enoxaparin API Product Portfolio

6.2.5 Sanofi S.A. Recent Developments/Updates

6.3 GlaxoSmithKline Plc

6.3.1 GlaxoSmithKline Plc Corporation Information

6.3.2 GlaxoSmithKline Plc Description and Business Overview

6.3.3 GlaxoSmithKline Plc Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.3.4 GlaxoSmithKline Plc Enoxaparin API Product Portfolio

6.3.5 GlaxoSmithKline Plc Recent Developments/Updates

6.4 Bristol Myer Squibb Company

6.4.1 Bristol Myer Squibb Company Corporation Information

6.4.2 Bristol Myer Squibb Company Description and Business Overview

6.4.3 Bristol Myer Squibb Company Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bristol Myer Squibb Company Enoxaparin API Product Portfolio

6.4.5 Bristol Myer Squibb Company Recent Developments/Updates

6.5 Bohehringer Ingelheim

6.5.1 Bohehringer Ingelheim Corporation Information

6.5.2 Bohehringer Ingelheim Description and Business Overview

6.5.3 Bohehringer Ingelheim Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Bohehringer Ingelheim Enoxaparin API Product Portfolio

6.5.5 Bohehringer Ingelheim Recent Developments/Updates

6.6 Eisai Inc.

6.6.1 Eisai Inc. Corporation Information

6.6.2 Eisai Inc. Description and Business Overview

6.6.3 Eisai Inc. Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Eisai Inc. Enoxaparin API Product Portfolio

6.6.5 Eisai Inc. Recent Developments/Updates

6.7 Teva Pharmaceutical Industries Ltd.

6.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information

6.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview

6.6.3 Teva Pharmaceutical Industries Ltd. Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Teva Pharmaceutical Industries Ltd. Enoxaparin API Product Portfolio

6.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

6.8 Abbot India Limited, Novartis AG

6.8.1 Abbot India Limited, Novartis AG Corporation Information

6.8.2 Abbot India Limited, Novartis AG Description and Business Overview

6.8.3 Abbot India Limited, Novartis AG Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Abbot India Limited, Novartis AG Enoxaparin API Product Portfolio

6.8.5 Abbot India Limited, Novartis AG Recent Developments/Updates

6.9 ChemWerth

6.9.1 ChemWerth Corporation Information

6.9.2 ChemWerth Description and Business Overview

6.9.3 ChemWerth Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.9.4 ChemWerth Enoxaparin API Product Portfolio

6.9.5 ChemWerth Recent Developments/Updates

6.10 Laboratorios Farmaceuticos ROVI SA

6.10.1 Laboratorios Farmaceuticos ROVI SA Corporation Information

6.10.2 Laboratorios Farmaceuticos ROVI SA Description and Business Overview

6.10.3 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Laboratorios Farmaceuticos ROVI SA Enoxaparin API Product Portfolio

6.10.5 Laboratorios Farmaceuticos ROVI SA Recent Developments/Updates

6.11 Gland Pharma Limited

6.11.1 Gland Pharma Limited Corporation Information

6.11.2 Gland Pharma Limited Enoxaparin API Description and Business Overview

6.11.3 Gland Pharma Limited Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Gland Pharma Limited Enoxaparin API Product Portfolio

6.11.5 Gland Pharma Limited Recent Developments/Updates

6.12 Hanways Chempharma Co. Ltd

6.12.1 Hanways Chempharma Co. Ltd Corporation Information

6.12.2 Hanways Chempharma Co. Ltd Enoxaparin API Description and Business Overview

6.12.3 Hanways Chempharma Co. Ltd Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Hanways Chempharma Co. Ltd Enoxaparin API Product Portfolio

6.12.5 Hanways Chempharma Co. Ltd Recent Developments/Updates

6.13 Changzhou Qianhong Biopharma

6.13.1 Changzhou Qianhong Biopharma Corporation Information

6.13.2 Changzhou Qianhong Biopharma Enoxaparin API Description and Business Overview

6.13.3 Changzhou Qianhong Biopharma Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Changzhou Qianhong Biopharma Enoxaparin API Product Portfolio

6.13.5 Changzhou Qianhong Biopharma Recent Developments/Updates

6.14 Shenzhen Hepalink Pharmaceutical Group

6.14.1 Shenzhen Hepalink Pharmaceutical Group Corporation Information

6.14.2 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Description and Business Overview

6.14.3 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Product Portfolio

6.14.5 Shenzhen Hepalink Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Enoxaparin API Industry Chain Analysis

7.2 Enoxaparin API Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Enoxaparin API Production Mode & Process

7.4 Enoxaparin API Sales and Marketing

7.4.1 Enoxaparin API Sales Channels

7.4.2 Enoxaparin API Distributors

7.5 Enoxaparin API Customers

8 Enoxaparin API Market Dynamics

8.1 Enoxaparin API Industry Trends

8.2 Enoxaparin API Market Drivers

8.3 Enoxaparin API Market Challenges

8.4 Enoxaparin API Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Sanofi

GlaxoSmithKline PLC

Bristol Myer Squibb Company

Eisai Co Ltd

Teva Pharmaceutical Industries Ltd

ChemWerth Inc

Gland Pharma Limited

Bohehringer Ingelheim

Abbot India Limited, Novartis AG

Laboratorios Farmaceuticos ROVI SA

Hanways Chempharma Co. Ltd

Changzhou Qianhong Biopharma

Shenzhen Hepalink Pharmaceutical Group

List of Tables

Table 1. Global Enoxaparin API Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Enoxaparin API Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Enoxaparin API Market Competitive Situation by Manufacturers in 2023

Table 4. Global Enoxaparin API Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Enoxaparin API Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Enoxaparin API Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Enoxaparin API Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Enoxaparin API Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Enoxaparin API, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Enoxaparin API, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Enoxaparin API, Product Type & Application

Table 12. Global Key Manufacturers of Enoxaparin API, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Enoxaparin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin API as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Enoxaparin API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Enoxaparin API Sales by Region (2019-2024) & (K Units)

Table 18. Global Enoxaparin API Sales Market Share by Region (2019-2024)

Table 19. Global Enoxaparin API Sales by Region (2025-2030) & (K Units)

Table 20. Global Enoxaparin API Sales Market Share by Region (2025-2030)

Table 21. Global Enoxaparin API Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Enoxaparin API Revenue Market Share by Region (2019-2024)

Table 23. Global Enoxaparin API Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Enoxaparin API Revenue Market Share by Region (2025-2030)

Table 25. North America Enoxaparin API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Enoxaparin API Sales by Country (2019-2024) & (K Units)

Table 27. North America Enoxaparin API Sales by Country (2025-2030) & (K Units)

Table 28. North America Enoxaparin API Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Enoxaparin API Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Enoxaparin API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Enoxaparin API Sales by Country (2019-2024) & (K Units)

Table 32. Europe Enoxaparin API Sales by Country (2025-2030) & (K Units)

Table 33. Europe Enoxaparin API Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Enoxaparin API Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Enoxaparin API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Enoxaparin API Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Enoxaparin API Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Enoxaparin API Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Enoxaparin API Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Enoxaparin API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Enoxaparin API Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Enoxaparin API Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Enoxaparin API Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Enoxaparin API Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Enoxaparin API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Enoxaparin API Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Enoxaparin API Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Enoxaparin API Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Enoxaparin API Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Enoxaparin API Sales (K Units) by Type (2019-2024)

Table 51. Global Enoxaparin API Sales (K Units) by Type (2025-2030)

Table 52. Global Enoxaparin API Sales Market Share by Type (2019-2024)

Table 53. Global Enoxaparin API Sales Market Share by Type (2025-2030)

Table 54. Global Enoxaparin API Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Enoxaparin API Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Enoxaparin API Revenue Market Share by Type (2019-2024)

Table 57. Global Enoxaparin API Revenue Market Share by Type (2025-2030)

Table 58. Global Enoxaparin API Price (US$/Unit) by Type (2019-2024)

Table 59. Global Enoxaparin API Price (US$/Unit) by Type (2025-2030)

Table 60. Global Enoxaparin API Sales (K Units) by Application (2019-2024)

Table 61. Global Enoxaparin API Sales (K Units) by Application (2025-2030)

Table 62. Global Enoxaparin API Sales Market Share by Application (2019-2024)

Table 63. Global Enoxaparin API Sales Market Share by Application (2025-2030)

Table 64. Global Enoxaparin API Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Enoxaparin API Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Enoxaparin API Revenue Market Share by Application (2019-2024)

Table 67. Global Enoxaparin API Revenue Market Share by Application (2025-2030)

Table 68. Global Enoxaparin API Price (US$/Unit) by Application (2019-2024)

Table 69. Global Enoxaparin API Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer Inc. Corporation Information

Table 71. Pfizer Inc. Description and Business Overview

Table 72. Pfizer Inc. Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Inc. Enoxaparin API Product

Table 74. Pfizer Inc. Recent Developments/Updates

Table 75. Sanofi S.A. Corporation Information

Table 76. Sanofi S.A. Description and Business Overview

Table 77. Sanofi S.A. Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Sanofi S.A. Enoxaparin API Product

Table 79. Sanofi S.A. Recent Developments/Updates

Table 80. GlaxoSmithKline Plc Corporation Information

Table 81. GlaxoSmithKline Plc Description and Business Overview

Table 82. GlaxoSmithKline Plc Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. GlaxoSmithKline Plc Enoxaparin API Product

Table 84. GlaxoSmithKline Plc Recent Developments/Updates

Table 85. Bristol Myer Squibb Company Corporation Information

Table 86. Bristol Myer Squibb Company Description and Business Overview

Table 87. Bristol Myer Squibb Company Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Bristol Myer Squibb Company Enoxaparin API Product

Table 89. Bristol Myer Squibb Company Recent Developments/Updates

Table 90. Bohehringer Ingelheim Corporation Information

Table 91. Bohehringer Ingelheim Description and Business Overview

Table 92. Bohehringer Ingelheim Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Bohehringer Ingelheim Enoxaparin API Product

Table 94. Bohehringer Ingelheim Recent Developments/Updates

Table 95. Eisai Inc. Corporation Information

Table 96. Eisai Inc. Description and Business Overview

Table 97. Eisai Inc. Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Eisai Inc. Enoxaparin API Product

Table 99. Eisai Inc. Recent Developments/Updates

Table 100. Teva Pharmaceutical Industries Ltd. Corporation Information

Table 101. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 102. Teva Pharmaceutical Industries Ltd. Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Teva Pharmaceutical Industries Ltd. Enoxaparin API Product

Table 104. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 105. Abbot India Limited, Novartis AG Corporation Information

Table 106. Abbot India Limited, Novartis AG Description and Business Overview

Table 107. Abbot India Limited, Novartis AG Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Abbot India Limited, Novartis AG Enoxaparin API Product

Table 109. Abbot India Limited, Novartis AG Recent Developments/Updates

Table 110. ChemWerth Corporation Information

Table 111. ChemWerth Description and Business Overview

Table 112. ChemWerth Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. ChemWerth Enoxaparin API Product

Table 114. ChemWerth Recent Developments/Updates

Table 115. Laboratorios Farmaceuticos ROVI SA Corporation Information

Table 116. Laboratorios Farmaceuticos ROVI SA Description and Business Overview

Table 117. Laboratorios Farmaceuticos ROVI SA Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Laboratorios Farmaceuticos ROVI SA Enoxaparin API Product

Table 119. Laboratorios Farmaceuticos ROVI SA Recent Developments/Updates

Table 120. Gland Pharma Limited Corporation Information

Table 121. Gland Pharma Limited Description and Business Overview

Table 122. Gland Pharma Limited Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Gland Pharma Limited Enoxaparin API Product

Table 124. Gland Pharma Limited Recent Developments/Updates

Table 125. Hanways Chempharma Co. Ltd Corporation Information

Table 126. Hanways Chempharma Co. Ltd Description and Business Overview

Table 127. Hanways Chempharma Co. Ltd Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Hanways Chempharma Co. Ltd Enoxaparin API Product

Table 129. Hanways Chempharma Co. Ltd Recent Developments/Updates

Table 130. Changzhou Qianhong Biopharma Corporation Information

Table 131. Changzhou Qianhong Biopharma Description and Business Overview

Table 132. Changzhou Qianhong Biopharma Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Changzhou Qianhong Biopharma Enoxaparin API Product

Table 134. Changzhou Qianhong Biopharma Recent Developments/Updates

Table 135. Shenzhen Hepalink Pharmaceutical Group Corporation Information

Table 136. Shenzhen Hepalink Pharmaceutical Group Description and Business Overview

Table 137. Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Shenzhen Hepalink Pharmaceutical Group Enoxaparin API Product

Table 139. Shenzhen Hepalink Pharmaceutical Group Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Enoxaparin API Distributors List

Table 143. Enoxaparin API Customers List

Table 144. Enoxaparin API Market Trends

Table 145. Enoxaparin API Market Drivers

Table 146. Enoxaparin API Market Challenges

Table 147. Enoxaparin API Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Enoxaparin API

Figure 2. Global Enoxaparin API Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Enoxaparin API Market Share by Type in 2023 & 2030

Figure 4. Multi Vials Product Picture

Figure 5. Pre-Filled Syringes Product Picture

Figure 6. Others Product Picture

Figure 7. Global Enoxaparin API Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Enoxaparin API Market Share by Application in 2023 & 2030

Figure 9. COVID-19

Figure 10. Pulmonary Embolism

Figure 11. Atrial Fibrillation

Figure 12. Others

Figure 13. Global Enoxaparin API Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Enoxaparin API Market Size (2019-2030) & (US$ Million)

Figure 15. Global Enoxaparin API Sales (2019-2030) & (K Units)

Figure 16. Global Enoxaparin API Average Price (US$/Unit) & (2019-2030)

Figure 17. Enoxaparin API Report Years Considered

Figure 18. Enoxaparin API Sales Share by Manufacturers in 2023

Figure 19. Global Enoxaparin API Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Enoxaparin API Players: Market Share by Revenue in 2023

Figure 21. Enoxaparin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Enoxaparin API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Enoxaparin API Sales Market Share by Country (2019-2030)

Figure 24. North America Enoxaparin API Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Enoxaparin API Sales Market Share by Country (2019-2030)

Figure 28. Europe Enoxaparin API Revenue Market Share by Country (2019-2030)

Figure 29. Germany Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Enoxaparin API Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Enoxaparin API Revenue Market Share by Region (2019-2030)

Figure 36. China Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Enoxaparin API Sales Market Share by Country (2019-2030)

Figure 47. Latin America Enoxaparin API Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Enoxaparin API Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Enoxaparin API Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Enoxaparin API Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Enoxaparin API by Type (2019-2030)

Figure 57. Global Revenue Market Share of Enoxaparin API by Type (2019-2030)

Figure 58. Global Enoxaparin API Price (US$/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Enoxaparin API by Application (2019-2030)

Figure 60. Global Revenue Market Share of Enoxaparin API by Application (2019-2030)

Figure 61. Global Enoxaparin API Price (US$/Unit) by Application (2019-2030)

Figure 62. Enoxaparin API Value Chain

Figure 63. Enoxaparin API Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions